Azafaros is developing new treatment options to help patients with rare metabolic disorders. Azafaros was founded in 2018 by a team of experienced industry professionals and scientists aspiring to address rare genetic metabolic disorders through a pipeline of oral small molecules with disease-modifying potential. 

Biotechnology

Azafaros

The Basel office focuses on advanced drug development and clinical trial management, ensuring high quality and compliance.

Basel

Azafaros' headquarters in Naarden, Netherlands

Stefano Portolano

Silvia Ragno

Henrik Torp Nielsen

Christian Freitag

Carlo Incerti

Vanessa King

Edward Van Wezel

Sander Slootweg

Kiran Dallenbach

This department oversees medical and regulatory functions related to clinical development and product approval.

Clinical Affairs

The Business Development and Strategy team at Azafaros is responsible for identifying and pursuing growth opportunities that align with the company's mission to develop innovative treatments for rare metabolic disorders. This includes forging strategic partnerships, navigating regulatory pathways, and engaging with stakeholders to ensure patient needs are met. The team also focuses on financial planning and resource allocation to effectively support the advancement of their drug pipeline.

Business Development and Strategy

This department oversees the planning, execution, and management of clinical trials to ensure they meet regulatory standards and are conducted efficiently.

Clinical Operations

The Clinical Operations and Development team at Azafaros is responsible for managing and overseeing the entire clinical trial process for new treatment options targeting rare metabolic disorders. This includes designing and implementing clinical studies, ensuring regulatory compliance, and collaborating with cross-functional teams to facilitate the successful progression of drug candidates from preclinical stages through clinical development. Their ultimate goal is to bring innovative therapies to patients while maintaining high standards of safety and efficacy.

Clinical Operations and Development

This department oversees the strategic direction and governance of the organization.

Executive Governance

The Leadership Team at Azafaros is responsible for setting the strategic direction of the company, overseeing operations, and ensuring the successful development of innovative treatment options for rare metabolic disorders. Comprising the CEO, COO, and CMO, this team drives collaboration across departments, aligns resources with business goals, and fosters partnerships that enhance research and development efforts. Their collective expertise guides Azafaros in navigating the complexities of the biotech landscape while prioritizing patient needs and scientific advancement.

Azafaros

Org chart

Board & advisors

Teams

Clinical Affairs

Business Development and Strategy

Clinical Operations

Clinical Operations and Development

Executive Governance

Leadership Team

Offices

Azafaros

Org chart

Board & advisors

Teams

Clinical Affairs

Business Development and Strategy

Clinical Operations

Clinical Operations and Development

Executive Governance

Leadership Team

Offices

Related companies